V Square Quantitative Management LLC Sells 6,093 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

V Square Quantitative Management LLC trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 12.9% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,234 shares of the pharmacy operator’s stock after selling 6,093 shares during the period. V Square Quantitative Management LLC’s holdings in Walgreens Boots Alliance were worth $385,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently modified their holdings of the company. First Financial Corp IN boosted its holdings in shares of Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares in the last quarter. Golden State Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance in the 4th quarter worth $26,000. TD Private Client Wealth LLC lifted its holdings in shares of Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 3,208 shares in the last quarter. Sentry Investment Management LLC bought a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth $30,000. Finally, Eastern Bank bought a new position in shares of Walgreens Boots Alliance in the 3rd quarter worth $33,000. 58.59% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on WBA. Jefferies Financial Group cut their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Truist Financial cut their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a report on Friday, January 31st. Bank of America increased their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Finally, Royal Bank of Canada raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $13.19.

View Our Latest Analysis on Walgreens Boots Alliance

Walgreens Boots Alliance Trading Down 0.5 %

Shares of WBA opened at $9.70 on Monday. The business has a 50-day moving average of $10.31 and a 200 day moving average of $9.74. Walgreens Boots Alliance, Inc. has a fifty-two week low of $8.08 and a fifty-two week high of $22.47. The firm has a market cap of $8.38 billion, a P/E ratio of -0.95, a price-to-earnings-growth ratio of 1.26 and a beta of 0.65. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. During the same quarter last year, the firm posted $0.66 EPS. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Walgreens Boots Alliance Company Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.